GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Synthaverse SA (WAR:SVE) » Definitions » Additional Paid-In Capital

Synthaverse (WAR:SVE) Additional Paid-In Capital : zł121.33 Mil(As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Synthaverse Additional Paid-In Capital?


Synthaverse's quarterly additional paid-in capital declined from Mar. 2024 (zł120.79 Mil) to Jun. 2024 (zł120.76 Mil) but then increased from Jun. 2024 (zł120.76 Mil) to Sep. 2024 (zł121.33 Mil).

Synthaverse's annual additional paid-in capital increased from Dec. 2021 (zł95.03 Mil) to Dec. 2022 (zł119.46 Mil) and increased from Dec. 2022 (zł119.46 Mil) to Dec. 2023 (zł120.82 Mil).

Synthaverse Additional Paid-In Capital Historical Data

The historical data trend for Synthaverse's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synthaverse Additional Paid-In Capital Chart

Synthaverse Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 62.34 62.34 95.03 119.46 120.82

Synthaverse Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 120.20 120.82 120.79 120.76 121.33

Synthaverse Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Synthaverse Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Synthaverse's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Synthaverse Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Synthaverse SA (WAR:SVE) » Definitions » Additional Paid-In Capital
Comparable Companies
WAR:BIO WAR:CTX WAR:BCX WAR:PTG WAR:MOC WAR:MAB WAR:URT WAR:NNG WAR:PUR WAR:RDG VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
N/A
Address
10, Uniwersytecka street, Lublin, POL, 20-029
Website
https://synthaverse.pl
Synthaverse SA is a global pharmaceutical company. Its goal is to provide the best, innovative and unique solutions for medicine. Its work is based on scientific and health knowledge. Along with its expert approach, it allows the company to create reliable and unique products. It manufactures one of the few drugs used internationally in the oncological immunotherapy of bladder cancer.

Synthaverse Headlines

No Headlines